TFS
BSX icon

Thoroughbred Financial Services’s Boston Scientific BSX Stock Holding History

Thoroughbred Financial Services’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,694
Closed -$1.02M – 578
2025
Q4 		$1.02M Buy
10,694
+8,267
+341% +$811K 0.06% 276
2025
Q3 		$236K Sell
2,427
-3
-0.1% -$311 0.01% 517
2025
Q2 		$261K Buy
2,430
+67
+3% +$6.78K 0.02% 497
2025
Q1 		$238K Sell
2,363
-286
-11% -$28.8K 0.01% 612
2024
Q4 		$236K Hold
2,649
– – 0.01% 608
2024
Q3 		$221K Hold
2,649
– – 0.01% 600
2024
Q2 		$203K Buy
+2,649
New +$194K 0.01% 602

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Thoroughbred Financial Services's BSX Position: Q1 2026 in Review

Thoroughbred Financial Services sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 10,694 shares — an estimated $1.02M sold.

Thoroughbred Financial Services first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $1.02M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Thoroughbred Financial Services reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Thoroughbred Financial Services sold 10,694 Boston Scientific shares in Q1 2026, an estimated $1.02M.
  • Thoroughbred Financial Services first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
  • Thoroughbred Financial Services's Boston Scientific position peaked at $1.02M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Thoroughbred Financial Services's 13F filing for Q1 2026, filed 12 May 2026.